1 HOCM patients (n=29) had Doppler echocardiography at bas
2 HOCM patients had larger atria, which had a higher eject
3 Of
101 HOCM urograms, only two (2%) showed striations.
4 ressure gradient on 5 consecutive days in
12 HOCM patients and 5 aortic stenosis control subjects.
5 side of the septum and echocardiograms on
15 HOCM patients at baseline and after successful NSRT.
6 The
25 HOCM patients had left heart catheterization, and 16 wer
7 , function, and outflow tract gradient of
26 HOCM patients (53+/-15 years old) who underwent NSRT wer
8 An initial group of
30 HOCM patients (age 46 +/- 17, 16 women) who underwent NS
9 ith hypertrophic obstructive
cardiomyopathy (
HOCM) both acutely and on a long-term basis.
10 Hypertrophic obstructive
cardiomyopathy (
HOCM) is characterized by left ventricular hypertrophy (
11 ith hypertrophic obstructive
cardiomyopathy (
HOCM) undergoing extended transaortic septal myectomy.
12 ith hypertrophic obstructive
cardiomyopathy (
HOCM) unresponsive to medications.
13 ith hypertrophic obstructive
cardiomyopathy (
HOCM) who underwent either percutaneous transluminal sep
14 ith hypertrophic obstructive
cardiomyopathy (
HOCM), 10 patients with aortic valve stenosis, and 14 he
15 ory hypertrophic obstructive
cardiomyopathy (
HOCM), the procedure remains subjective.
16 of hypertrophic obstructive
cardiomyopathy (
HOCM).
17 ith hypertrophic obstructive
cardiomyopathy (
HOCM).
18 ith hypertrophic obstructive
cardiomyopathy (
HOCM).
19 of hypertrophic obstructive
cardiomyopathy (
HOCM).
20 ith hypertrophic obstructive
cardiomyopathy (
HOCM).
21 ith hypertrophic obstructive
cardiomyopathy (
HOCM).
22 for hypertrophic obstructive
cardiomyopathy (
HOCM).
23 ith hypertrophic obstructive
cardiomyopathy (
HOCM).
24 ith hypertrophic obstructive
cardiomyopathy (
HOCM).
25 ith hypertrophic obstructive
cardiomyopathy (
HOCM).
26 in hypertrophic obstructive
cardiomyopathy (
HOCM).
27 elated with echocardiographic parameters
for HOCM.
28 non-obstructive (HNCM) and obstructive
form (
HOCM) therefore requiring personalized therapeutic thera
29 versus 42+/-6%) and was further decreased
in HOCM (22+/-5%).
30 External work did not differ
in HOCM compared with controls, whereas myocardial oxygen c
31 ygen consumption was significantly higher
in HOCM than in controls and genotype positive/phenotype ne
32 antly delayed in HCM patients and longest
in HOCM patients.
33 s myocardial oxygen consumption was lower
in HOCM.
34 Deformation measurements were the lowest
in HOCM patients and increased (p<0.05) after septal reduct
35 ry to disease remodeling underlie low MEE
in HOCM.
36 the severity of dynamic LVOT obstruction
in HOCM.
37 We suggest that pressure overload
in HOCM patients contributes to the development of hypertro
38 Follow-up measurements were performed
in HOCM and aortic valve stenosis patients 4 months after s
39 c obstruction leads to delayed untwisting
in HOCM, which accounts well for the increased LV filling p
40 ther LOCM or high-osmolality contrast
media (
HOCM) were reviewed.
41 or patients with drug-refractory symptoms
of HOCM; however, its benefits in comparison to surgery are
42 SA does seem to show promise in treatment
of HOCM owing to similar mortality rates as well as functio
43 onsidered the gold standard for treatment
of HOCM.
44 comparing control subjects with HCM, HNCM
or HOCM patients (AUC from 0.722 to 0.949).
45 ceived LOCM; at the second, 101 had
received HOCM.
46 or symptomatic patients with drug-
refractory HOCM is unknown.
47 Thirty-nine patients with
symptomatic HOCM were analyzed in this concurrent cohort study.
48 nctional status in patients with
symptomatic HOCM.
49 age 11.1 +/- 6 years, range 1 to 17.5)
with HOCM and a Doppler LVOT gradient > or = 40 mm Hg were st
50 in order to induce an MI in 51 patients
with HOCM (age 55 +/- 2 years).
51 nosis, MEE was not improved in patients
with HOCM after surgery, which was explained by opposite chan
52 RT reduces LVOT obstruction in patients
with HOCM and leads to symptomatic improvement.
53 Twenty-nine patients
with HOCM and maximal medical therapy underwent NSRT.
54 We enrolled 33 symptomatic patients
with HOCM and obstruction (>/=40 mm Hg gradient at rest or >/
55 Patients
with HOCM frequently have enlarged left atria, which predispo
56 Patients
with HOCM have reduced exercise tolerance.
57 ed ethanol septal reduction in patients
with HOCM is a safe, minimally invasive procedure that provid
58 Of 51 patients
with HOCM treated, 25 were treated by PTSMA and 26 patients v
59 Thirty patients
with HOCM underwent treadmill exercise testing as well as 2-d
60 3 patients
with HOCM were chosen for the application of the proposed pro
61 We enrolled 25 patients
with HOCM, 20 with hypertrophic cardiomyopathy (HCM), and 20
62 In most patients
with HOCM, MR related to systolic anterior motion of the MV i
63 r mitral regurgitation (MR) in patients
with HOCM.
64 icators of disease severity in patients
with HOCM.
65 fective procedure for treating patients
with HOCM.
66 ese two forms of treatment for patients
with HOCM.
67 prove NYHA functional class in patients
with HOCM.
68 ably from day to day in stable patients
with HOCM.
69 bility of the LVOT gradient in patients
with HOCM.
70 and relieve symptoms in adult patients
with HOCM.
71 therapy for selected pediatric patients
with HOCM.
72 ent preoperative assessment of patients
with HOCM.